The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApax Global Alpha Regulatory News (APAX)

Share Price Information for Apax Global Alpha (APAX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 151.60
Bid: 151.00
Ask: 152.00
Change: 1.20 (0.80%)
Spread: 1.00 (0.662%)
Open: 150.80
High: 152.80
Low: 150.80
Prev. Close: 150.40
APAX Live PriceLast checked at -
Apax Global Alpha is an Investment Trust

To provide shareholders with capital appreciation from our investment portfolio and regular dividends.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2020 Interim Results Highlights

25 Aug 2020 07:00

RNS Number : 0183X
Apax Global Alpha Limited
25 August 2020
 

(LSE: APAX)

 

 

Apax Global Alpha Limited

Unaudited interim results for the half-year ended 30 June 2020

 

For further information regarding the announcement of AGA's 2020 first half results, including the details for today's analyst and investor webcast at 9.30am (UK time), please visit www.apaxglobalalpha.com.

 

 

Covid-19 update

 

· The economic outlook remains highly uncertain. While countries have begun to rebound as they have reopened from lockdowns, levels of GDP remain well below pre-Covid levels in most economies. The speed of recovery will depend on the evolution of the pandemic, medical interventions, policy responses, and general consumer and business confidence. The recovery is unlikely to be linear and, for most economies, economic activity may not return to pre-Covid levels until 2022. The impact and recovery is, however, very different between sectors. Tech in general has proved more resilient and is expected to grow over the coming years driven by underlying trends. Offline retail has been severely impacted and is recovering more slowly.

 

· With the portfolio proving resilient in the first half of 2020, we believe that the Apax Funds' focus on: i) drawing on the Investment Advisor's sub-sector expertise, particularly in those subsectors benefiting from digitisation trends; ii) driving business transformation, the pace of which has only increased in the past five months; and iii) investing with modest average entry leverage levels, will leave the portfolio well-positioned coming out of this current crisis.

 

· AGA's liquidity position remains healthy. At 30 June 2020, AGA had cash of €33.8m and its revolving credit facility of €140.0m remained undrawn. Derived Investments of €281.5m provide a further source of capital for AGA to meet its commitments to the Apax Funds.

 

 

Key highlights

 

· Interim dividend of 4.87 pence per share declared, equivalent to 2.5% of the euro NAV as at 30 June 2020.

 

· H1 2020 Total NAV Return1 was broadly flat at (0.5)% (0.6% constant currency). Following a negative return of 11.9% in the first quarter of 2020 reflecting general market weakness, valuations strongly recovered during the second quarter at 13.3%, especially in the Private Equity portfolio.

 

· Contributions to Total NAV Return1 of (0.5)% were:

o Private Equity 2.0%

o Derived Debt (0.2)%

o Derived Equity (0.9)%

o Costs, FX and other movements (1.4)%

 

· Adjusted NAV grew back to over €1bn at 30 June 2020, at €1,060.7m, with NAV and Adjusted NAV2 per share of €2.16/ £1.96.

 

· At 30 June 2020, the Invested Portfolio was split 72% Private Equity and 28% Derived Investments and it is expected that AGA will maintain the majority of its assets invested in Private Equity going forward.

 

· AGA follows the four Apax core sectors. As at 30 June 2020, the Invested Portfolio was split 44% Tech & Telco and Digital, 28%3 Services, 19% Healthcare and 9%3 Consumer.

 

 

 

 

Outstanding commitments and funding sources

 

· AGA was 97% invested with cash of €33.8m.

 

· Outstanding commitments to the Apax Funds (together with recallable distributions and the new AX commitment) amounted to €499.2m (47.1% of NAV). In addition to future Private Equity distributions, funding sources that can be accessed to fund future Private Equity calls include Derived Investments of €281.5m, an undrawn revolving credit facility of €140.0m, cash of €33.8m, and net current assets of €2.9m.

 

Adjusted NAV2 movements (€m)

Private Equity

Derived Investments

Cash

 

Treasury Shares

Facility drawn

Other4

 

H120 Total

Adjusted NAV at 31.12.19

759.4

342.2

3.3

-

-

(12.8)

1,092.1

+ Investments

20.7

15.7

(49.8)

-

-

13.4

-

- Distributions/ divestments

(61.8)

(50.6)

109.6

-

-

2.8

-

+ Interest and dividend income

-

-

9.5

-

-

(0.5)

9.0

+/- Unrealised gains/(losses)

25.2

(24.6)

-

-

-

-

0.6

+/- Realised gains/(losses)

-

2.2

-

-

-

-

2.2

+/- FX gains/(losses)5

(7.9)

(3.4)

(2.4)

-

-

-

(13.7)

+/- Costs and other movements

-

-

(3.8)

-

-

-

(3.8)

 - Dividends paid

-

-

(25.7)

-

-

-

(25.7)

+/- Performance fee reserve6

6.9

-

-

(6.9)

-

-

-

+/- Treasury shares

-

-

(6.9)

6.9

-

-

-

+/- Revolving credit facility

drawn/repaid

-

-

-

-

-

-

-

Adjusted NAV at 30.06.207

742.5

281.5

33.8

-

-

2.9

1,060.7

         

 

 

Private Equity portfolio highlights

 

· The Private Equity portfolio delivered a resilient performance in H1 2020 with a Total Return1 of +2.3% (+3.4% constant currency).

 

· Tech & Telco remains the most heavily weighted sector, accounting for 41% of the Private Equity portfolio, followed by 30%3 in Services, 16% in Healthcare, and 12%3 in Consumer.

 

· On a look-through basis, AGA invested c.€58.2m in six new investments (Cadence Education, Coalfire Systems, Verint Systems, KAR Global, Accurate Background, and Prove) and exited three positions (Sophos, Aptos, and Engineering10) during the period.

 

· Calls of €20.7m were paid to Apax VIII, AMI Opportunities and the Apax Digital Fund.

 

· Distributions totalled €61.8m; €17.6m from Apax Europe VII in relation to the sale of Sophos and Aptos, plus €43.2m from Apax VIII related to the partial realisations of TietoEVRY, Duck Creek, Exact and Neuraxpharm.

 

· Aggregate Gross IRR7 and Gross MOIC7 on Private Equity full exits in H1 2020 were 25.7% and 3.6x.

 

· Unrealised gains were €25.2m and unfavourable FX movements were €7.9m.

 

 

Private Equity - operational metrics

30 June 2020

31 December 2019

Portfolio year-over-year LTM revenue growth8

11.0%

20.9%

Portfolio year-over-year LTM EBITDA growth8

16.0%

15.9%

Enterprise Value / EBITDA valuation multiple8

17.0x

17.2x

Net debt / EBITDA multiple8

4.2x

3.7x

Number of closed investments in the period11

6

13

Number of exits for the period12

3

7

     

 

 

 

 

 

Derived Investments portfolio highlights

 

· Derived Investments leverage the insights and expertise of the Investment Advisor. The portfolio is weighted towards Tech & Telco, accounting for 53% of the Derived Investments portfolio.

 

· The portfolio is split 82% in Derived Debt and 18% in Derived Equity.

 

· A combination of Derived Debt Total Return1 of (1.5)% ((1.1)% constant currency) and Derived Equity Total Return1 of (18.4)% ((15.1)% constant currency) led to an overall Total Return1 of (5.3)% for Derived Investments ((4.2)% constant currency).

 

· Derived Debt performance H1 2020 with Total Return of (1.5)% comprised:

o Income 3.6%

o Realised gains 0.1%

o Unrealised losses (4.8)%

o FX (0.4)%

 

· Derived Equity performance H1 2020 with Total Return of (18.4)% comprised:

o Income 0.1%

o Realised gains 2.7%

o Unrealised losses (17.9)%

o FX (3.3)%

 

· New investments of €15.7m were all Derived Debt positions. AGA made three new investments in the period (Astra, Cotiviti, and Amerilife), of which two were first lien debt positions.

 

· AGA exited five debt positions and two equity investments with proceeds of €50.6m12

 

· Gross IRR14 on Derived Debt exits was 14.2% and Gross MOIC13 was 1.2x. Gross IRR13 on Derived Equity exits was 18.3% and Gross MOIC13 was 1.7x.

 

· Realised gains were €2.2m and unrealised losses of €24.5m stood against income of €9.0m and negative FX movements of €3.5m.

 

· FX exposure of c.72% in US dollar denominated investments.

 

Derived Investments - operational metrics

 

30 June 2020

31 December 2019

Debt year-over-year LTM EBITDA growth14

 

9.7%

14.6%

Debt average income yield to maturity14

 

9.2%

9.3%

Debt average years to maturity

 

5.7

6.0

Debt average income yield15

 

7.8%

8.9%

Equity year-over-year LTM earnings growth16

 

7.0%

24.8%

Equity price-to-earnings ratio16

 

20.8x

20.7x

Number of investments for the period11

 

4

13

Number of full exits for the period12

 

7

13

 

 

Other Invested Portfolio highlights

 

Invested Portfolio analysis17

€m

€m

%

%

Private Equity

742.5

 

72%

 

- AMI

 

22.4

 

2%

- AEVI

 

4.8

 

1%

- AEVII

 

29.7

 

3%

- AVIII

 

252.5

 

25%

- AIX

 

414.9

 

40%

- ADF

 

23.0

 

2%

- AX

 

(4.9)

 

(1)%

Derived Investments

281.5

 

28%

 

- Derived Debt

 

230.8

 

22%

- Derived Equity

 

50.7

 

5%

Total

1,024.0

 

100%

100%

 

 

 

Commenting on the results, Tim Breedon CBE, Chairman of Apax Global Alpha, said:

 

"As we look into an uncertain economic future, we draw confidence from the resilience our portfolio has shown during the crisis to date and believe that the sector-focused approach provides long-term value generation opportunities and an attractive yield to our shareholders."

 

 

 

Commenting on the results, Ralf Gruss, COO of Apax Partners, said:

 

"We are pleased that AGA's NAV grew back to over €1bn. The portfolio has benefited from its overweight position in Tech & Telco and Digital and portfolio companies increasing their operating leverage. We believe the portfolio is well-positioned coming out of the crisis to generate attractive returns in this challenging environment."

 

For more information, the Company's latest results presentation is available to view at: www.apaxglobalalpha.com 

 

 

 

Contact details

Lorraine Rees

Investor Relations - AGA

 

Telephone: +44 (0)20 7872 6381

 

Email: lorraine.rees@apax.com

 

 

 

 

 

 

Footnotes

 

 

1.

"Total NAV Return" means the movement in the Adjusted NAV per share over the quarter plus any dividends paid. "Total Return" reflects the sub-portfolio performance on a stand-alone basis. It excludes items at the overall AGA level such as cash, management fees, and costs

2.

Adjusted NAV and NAV were the same at €1,060.7m as the performance fee reserve was nil at period end

3.

At June 2020, percentages of Services and Consumer have been amended to reflect the reclassification of two online market place businesses (Idealista and Baltics Classifieds Group) from Consumer to Services

4.

Movement of €15.7m was mainly due to the settlement of an investment traded just prior to year-end that settled in H1 2020

5.

FX on cash includes the revaluation of cash balances and net losses arising from the differences in exchange rates between transaction dates and settlement dates, and unrealised net losses arising from the translation into euro of assets and liabilities (other than investments) which are not denominated in euro

6.

Movement in the Private Equity performance fee reserve of €6.9m reflects settlement of the performance fee reserve by the Company's purchase of shares in the market and subsequent issuance of those shares to the Investment Manager. This does not represent the underlying Private Equity portfolio's carried interest. There was no performance fee accrued during H1 2020

7.

Private Equity Aggregate Gross IRR and Gross MOIC calculated based on the expected aggregate cash flows in euro across all funds or the deals transacted in the period Sophos, Aptos and Engineering. Gross IRR represents concurrent Gross IRR.

8.

Gross Asset Value weighted average of the respective metric across the portfolio. At December 2019 and June 2020, 20 and 24 investments were respectively excluded as these are financial services companies often valued on book value or for which earnings financials are not available e.g. complex carve-outs or growth investments

9.

Private Equity investments closed in the first six months of 2020. Both Cadence Education and Accurate Background closed in March 2020, Coalfire in April 2020, Verint in May 2020 and both KAR Global and Prove closed in June 2020

10.

Represents Private Equity exits which were closed or signed but not yet closed in the first six months of 2020. Both Sophos and Aptos closed in March 2020 and Engineering was signed but closed just after period end in July 2020

11.

Represents new Derived Investments in H1 2020. Three new debt investments: Astra, Amerilife and Cotiviti. There were no new equity positions. Additionally, AGA paid delayed drawdowns of €2.2m to EverCommerce

12.

Derived Investments divestments in the first six months of 2020. €50.6m consists of €24.8m from five debt positions exited, €23.1m from two equity positions fully exited and €2.7m from two other partial equity sales

13.

Derived Investments Gross IRR and Gross MOIC calculated based on aggregate euro cash flows since inception for deals fully exited during H1 2020; Amerilife 1L and 2L (Debt), Boats Group (Debt), Safetykleen (Debt), Cotiviti (Debt), Strides (Equity) and Sophos (Equity)

14.

Gross Asset Value weighted average of the respective metric across the Derived Debt portfolio. (FullBeauty was excluded from LTM EBITDA growth)

15.

Gross Asset Value weighted average of the current full year income (annual coupon/clean price as at the respective date) for each debt position in the Derived Debt portfolio as at the respective date

16.

Gross Asset Value weighted average of the respective metric across the Derived Equity portfolio. (Answers, Airtel Africa and Cengage were excluded from both LTM earnings growth and P/E ratio)

17.

Invested Portfolio excludes cash and cash equivalents, revolving credit facility drawn and net current assets, including these the NAV is €1,060.7m and Adjusted NAV was the same as there was no performance fee reserve at 30 June 2020

 

 

 

 

 

Notes

 

1.

Note that references in this announcement to Apax Global Alpha Limited have been abbreviated to "AGA" or "the Company". References to Apax Partners LLP have been abbreviated to "Apax Partners" or "the Investment Adviser"

 

2.

Please be advised that this announcement may contain inside information as stipulated under the Market Abuse Regulations (EU) NO. 596/2014 ("MAR")

 

3.

This announcement is not for release, publication or distribution, directly or indirectly, in whole or in part, into or within the United States or to "US persons" (as defined in Regulation S under the United States Securities Act of 1933, as amended (the "Securities Act")) or into or within Australia, Canada, South Africa or Japan. Recipients of this announcement in jurisdictions outside the UK should inform themselves about and observe any applicable legal requirements in their jurisdictions. In particular, the distribution of the announcement may be restricted by law in certain jurisdictions

 

4.

The information presented herein is not an offer for sale within the United States of any equity shares or other securities of Apax Global Alpha Limited ("AGA"). AGA has not been and will not be registered under the US Investment Company Act of 1940, as amended (the "Investment Company Act"). In addition, AGA's shares (the "Shares") have not been and will not be registered under the Securities Act or any other applicable law of the United States. Consequently, the Shares may not be offered or sold or otherwise transferred within the United States, or to, or for the account or benefit of, US Persons, except pursuant to an exemption from the registration requirements of the Securities Act and under circumstances which will not require AGA to register under the Investment Company Act. No public offering of the Shares is being made in the United States

 

5.

This announcement may include forward-looking statements. The words "expect", "anticipate", "intends", "plan", "estimate", "aim", "forecast", "project" and similar expressions (or their negative) identify certain of these forward-looking statements. These forward-looking statements are statements regarding AGA's intentions, beliefs or current expectations concerning, among other things, AGA's results of operations, financial condition, liquidity, prospects, growth and strategies. The forward-looking statements in this presentation are based on numerous assumptions regarding AGA's present and future business strategies and the environment in which AGA will operate in the future. Forward-looking statements involve inherent known and unknown risks, uncertainties and contingencies because they relate to events and depend on circumstances that may or may not occur in the future and may cause the actual results, performance or achievements of AGA to be materially different from those expressed or implied by such forward looking statements. Many of these risks and uncertainties relate to factors that are beyond AGA's ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behaviour of other market participants, the actions of regulators and other factors such as AGA's ability to continue to obtain financing to meet its liquidity needs, changes in the political, social and regulatory framework in which AGA operates or in economic or technological trends or conditions. Past performance should not be taken as an indication or guarantee of future results, and no representation or warranty, express or implied, is made regarding future performance. AGA expressly disclaims any obligation or undertaking to release any updates or revisions to these forward-looking statements to reflect any change in AGA's expectations with regard thereto or any change in events, conditions or circumstances on which any statement is based after the date of this announcement, or to update or to keep current any other information contained in this announcement. Accordingly, undue reliance should not be placed on the forward-looking statements, which speak only as of the date of this announcement.

 

About Apax Global Alpha Limited

 

AGA is a Guernsey registered closed-ended collective investment scheme incorporated as a non-cellular company that listed on the London Stock Exchange on 15 June 2015. It is regulated by the Guernsey Financial Services Commission.

 

AGA's objective is to provide shareholders with capital appreciation from its investment portfolio and regular dividends. The Company is targeting an annualised Total Return, across economic cycles, of 12-15% (net of fees and expenses) including a dividend yield of 5% of Net Asset Value.

 

The investment policy of the Company is to make Private Equity investments in Apax Funds, and Derived Investments which are investments in equities and debt derived from the insights gained via Apax Partners' Private Equity activities.

 

Further information regarding the Company and its publications are available on the Company's website at www.apaxglobalalpha.com.

 

About Apax Partners LLP

 

Apax Partners LLP ("Apax Partners") is a leading global private equity advisory firm and over its more than 40-year history, Apax Partners has raised and advised funds with aggregate commitments of over €40 billion. Funds advised by Apax Partners invest in companies across four global sectors of Tech & Telco, Services, Healthcare and Consumer. These funds provide longterm equity financing to build and strengthen worldclass companies.

 

For further information about Apax Partners, please visit www.apax.com. Apax Partners is authorised and regulated by the Financial Conduct Authority in the UK.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR USSRRRUUWUUR
Date   Source Headline
7th May 20247:00 amRNSApax IX agrees to sell Healthium
2nd May 20247:00 amRNSAudit Committee Change
2nd May 20247:00 amRNSResult of AGM
2nd May 20247:00 amRNSQuarterly Results to 31 March 2024
24th Apr 20247:00 amRNSApax Funds to acquire IANS
18th Apr 20247:00 amRNSApax Funds To Acquire Zellis Group
5th Apr 20249:58 amRNSDirector/PDMR Shareholding
4th Apr 20242:02 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSNotice of Capital Markets Day
22nd Mar 202410:08 amRNSHolding in Company
11th Mar 20245:17 pmRNSPurchase of Ordinary Shares under IMA
5th Mar 20247:00 amRNS2023 Annual Dividend Declaration
5th Mar 20247:00 amRNSNotice of AGM
5th Mar 20247:00 amRNS2023 Annual Report and Accounts
5th Mar 20247:00 amRNS2023 Final Results
1st Mar 20242:00 pmRNSRetirement of Chris Ambler from the Board
28th Feb 20247:00 amRNSApax Funds Acquire IES
8th Feb 20247:00 amRNSEstimated Adjusted NAV as at 31 December 2023
2nd Feb 20247:00 amRNSApax Funds Acquire WGSN
4th Dec 20233:00 pmEQSHardman & Co Q&A on Apax Global Alpha: Hidden gems strategy delivering new investment opportunities
23rd Nov 202312:43 pmEQSHardman & Co Research on Apax Global Alpha (APAX): “Hidden Gems” strategy: green shoots into live deals
17th Nov 202312:58 pmRNSDirector/PDMR Shareholding
15th Nov 20237:00 amRNSApax Funds Invest in Petvisor
9th Nov 20237:00 amRNSQuarterly Results to 30 September 2023
27th Oct 20237:00 amRNSApax Funds Acquire GAN Integrity
12th Oct 20232:15 pmEQSHardman & Co Q&A on Apax Global Alpha (APAX): Confirming strong underlying competitive advantages
11th Oct 20237:00 amRNSApax Funds acquire Bazooka Candy Brands
5th Oct 20237:00 amRNSNotice of Q3 2023 Financial Results
2nd Oct 20237:00 amRNSDirectorate Change
25th Sep 20235:06 pmRNSHolding in Company
25th Sep 20232:45 pmEQSHardman & Co Research on Apax Global Alpha (APAX): Resilience in face of rising interest rates
12th Sep 202311:30 amRNSDirector/PDMR Shareholding
6th Sep 20237:02 amRNS2023 Interim Dividend
6th Sep 20237:01 amRNS2023 Interim Report and Accounts
6th Sep 20237:00 amRNS2023 Interim Results Highlights
7th Aug 20237:00 amRNSEstimated Adjusted NAV as at 30 June 2023
1st Aug 20237:00 amRNSFunds advised by Apax to acquire Palex
20th Jul 20234:35 pmEQSHardman & Co Q&A on Apax Global Alpha (APAX) Capital Markets Day: value added by the manager
5th Jul 20233:50 pmEQSHardman & Co Research on Apax Global Alpha (APAX) 2023 Capital Markets Day: accessing hidden gems
2nd Jun 20237:00 amRNSFunds advised by Apax invest in Swing Education
23rd May 20237:00 amRNSNotice of Capital Markets Day
16th May 20237:00 amRNSFunds advised by Apax to acquire IBS Software
4th May 20237:00 amRNSResult of AGM
4th May 20237:00 amRNSQuarterly results for 31 March 2023
21st Mar 20232:05 pmEQSHardman & Co Q&A on Apax Global Alpha (APAX): 2022 results adding value to companies leads to outperformance
14th Mar 20232:05 pmEQSHardman & Co Research on Apax Global Alpha (APAX): Outperformance by adding value to companies
13th Mar 20237:00 amRNSUpdate relating to SVB
2nd Mar 20237:00 amRNS2022 Annual Dividend Declaration
2nd Mar 20237:00 amRNSNotice of AGM
2nd Mar 20237:00 amRNS2022 Annual Report and Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.